SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 40 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,125,000 | $4,505,000 | 0.51% |
| DAFNA Capital Management LLC | 373,702 | $792,000 | 0.37% |
| BVF INC/IL | 1,684,636 | $3,571,000 | 0.35% |
| OIKOS HOLDINGS LLC | 182,395 | $387,000 | 0.24% |
| Eventide Asset Management | 2,265,455 | $4,803,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 512,036 | $1,086,000 | 0.17% |
| NEA Management Company, LLC | 1,298,274 | $2,752,000 | 0.13% |
| Palo Alto Investors LP | 1,162,473 | $2,464,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 427,642 | $907,000 | 0.09% |
| Telemetry Investments, L.L.C. | 90,781 | $192,000 | 0.07% |